🔗 Share this article

The prestigious award in medical science was granted for revolutionary findings that illuminate how the immune system attacks harmful pathogens while sparing the body's own cells.

Three renowned scientists—Japan's Shimon Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this accolade.

The work identified specialized "security guards" within the defense system that eliminate rogue defense cells capable of harming the body.

These findings are now paving the way for new therapies for immune disorders and cancer.

These winners will share a monetary award worth 11 million Swedish kronor.

Decisive Findings

"Their work has been decisive for comprehending how the body's defenses operates and the reason we don't all suffer from serious self-attack conditions," stated the chair of the Nobel Committee.

This team's research explain a core question: How does the immune system defend us from countless invaders while keeping our healthy cells unharmed?

Our body's protection system employs white blood cells that search for indicators of infection, including pathogens and bacteria it has not met before.

Such cells employ detectors—known as recognition units—that are produced by chance in a vast number of variations.

That provides the immune system the capacity to fight a wide array of invaders, but the unpredictability of the mechanism unavoidably creates immune cells that may attack the host.

Security Guards of the Body

Researchers previously knew that a portion of these harmful defense cells were destroyed in the immune organ—the site where immune cells mature.

This year's Nobel Prize recognizes the identification of T-reg cells—known as the body's "peacekeepers"—which patrol the system to neutralize other defenders that attack the body's own tissues.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.

The Nobel panel stated, "These discoveries have established a new field of investigation and spurred the creation of innovative treatments, for instance for tumors and immune disorders."

In malignancies, T-regs block the body from attacking the growth, so research are aimed at reducing their quantity.

In self-attack disorders, trials are exploring increasing T-reg cells so the body is not being harmed. A similar approach could also be effective in reducing the chances of transplanted organ rejection.

Innovative Experiments

Prof Sakaguchi, from Osaka University, conducted tests on mice that had their thymus removed, leading to self-attack conditions.

He demonstrated that introducing immune cells from healthy animals could prevent the illness—implying there was a system for preventing defenders from attacking the body.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were investigating an genetic immune disorder in mice and people that resulted in the discovery of a genetic factor critical for the way regulatory T-cells function.

"Their pioneering work has revealed how the immune system is controlled by regulatory T cells, stopping it from accidentally attacking the healthy cells," said a leading physiology specialist.

"The research is a remarkable example of how fundamental biological research can have broad implications for public health."